METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING AN ANTI-ERBB3 ANTIBODY

摘要

Provided are methods for treating pancreatic cancer in a patient by co-administering combinations of an anti-ErbB3 antibody and one or more additional therapeutic agents. Further disclosed are the combinations of therapies which include: the an(i-ErbB3 antibody is coadministered with irinotecan, the anti-ErbB3 antibody is co-administered with paclitaxel (e.g., nab-paclitaxel), and the anti-ErbB3 antibody is coadministered with erlotinib and gemcitabine.